HALEON UK TRADING SERVICES LIMITED
Get an alert when HALEON UK TRADING SERVICES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-09-25 (in 4mo)
Last made up 2025-09-11
Watchouts
None on the register
Cash
£2M
Latest balance sheet
Net assets
£46M
Equity attributable
Employees
0
Average over period
Profit before tax
£5M
Period ending 2024-12-31
Name history
Renamed 1 time since incorporation
- HALEON UK TRADING SERVICES LIMITED 2023-02-17 → present
- GLAXOSMITHKLINE CONSUMER TRADING SERVICES LIMITED 2012-06-21 → 2023-02-17
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £4,608,901,000 | £3,897,641,000 | |
| Operating profit | -£2,516,000 | -£5,240,000 | |
| Profit before tax | £4,216,000 | £4,773,000 | |
| Net profit | £3,194,000 | £3,483,000 | |
| Cash | £1,157,000 | £1,647,000 | |
| Total assets less current liabilities | £45,198,000 | £45,809,000 | |
| Net assets | £44,361,000 | £45,690,000 | |
| Equity | £44,361,000 | £45,690,000 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -0.1% | -0.1% | |
| Net margin | 0.1% | 0.1% | |
| Return on capital employed | -5.6% | -11.4% | |
| Gearing (liabilities / total assets) | 96.2% | 94.9% | |
| Current ratio | 1.01x | 1.03x | |
| Interest cover | -29.95x | -275.79x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having assessed the principal risks and considered other matters, the Directors are of the opinion that the current level of activity remains sustainable. The board of the ultimate parent company undertook an assessment of the ability of the Group (which includes this Company) to continue in operation and meet its liabilities as they fall due for the going concern assessment period. That assessment includes potential downside trading scenarios and the potential risks to customer demand and operational risks to distribution channels, operational risks to supply such as manufacturing site operations and materials. In addition to the above assessment, the Directors have obtained a letter of support from Haleon Intermediate Holdings Limited, an affiliate company within the Group, and have considered the Company's ability to take actions to ensure business continuity through operational channels and management of variable costs. As with any company placing reliance on other group entities for financial support, the Directors acknowledge that there can be no certainty that this support will continue, although at the date of approval of these financial statements, they have no reason to believe that it will not do so. On the basis of these considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HALEON UK CORPORATE SECRETARY LIMITED | Corporate Secretary | 2022-04-06 | — | — |
| BAIG, Arshad | Director | 2022-06-30 | Dec 1983 | British |
| HATTEEA, Haider Adam Claude | Director | 2021-11-01 | Feb 1980 | British |
| HALEON UK CORPORATE DIRECTOR LIMITED | Corporate Director | 2022-04-06 | — | — |
| HALEON UK CORPORATE SECRETARY LIMITED | Corporate Director | 2022-04-06 | — | — |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WHYTE, Victoria Anne | Secretary | 2012-06-21 | 2022-04-06 |
| ARISTIDOU, Antrinkos Andrew | Director | 2019-08-19 | 2020-03-10 |
| BOURGEOIS, Scott Christopher | Director | 2022-06-01 | 2022-12-16 |
| BOX, Jonathan Wilson | Director | 2016-06-17 | 2017-11-30 |
| BURNS, Alan George | Director | 2012-12-13 | 2016-08-01 |
| COOPER, Nicholas Ian | Director | 2021-11-01 | 2022-06-01 |
| COOPER, Nicholas Ian | Director | 2019-09-11 | 2020-03-10 |
| FALLON, Pauline Anne, Dr | Director | 2021-11-01 | 2022-12-16 |
| FOSTER-HAWES, Melanie | Director | 2016-06-17 | 2019-01-15 |
| GREEN, Richard | Director | 2017-11-30 | 2020-03-10 |
| HESTLER, Tobias Hannes | Director | 2019-01-15 | 2020-03-10 |
| LYNCH, Aidan | Director | 2019-04-30 | 2022-06-30 |
| O'HARA, Neil | Director | 2013-03-25 | 2021-12-31 |
| PREECE, Jonathan Paul | Director | 2021-11-01 | 2025-04-25 |
| TEACA, Ana Maria | Director | 2022-12-16 | 2025-03-25 |
| TREN, Nicholas Stephen Rudolph | Director | 2020-03-10 | 2021-12-31 |
| WILLIAMSON, Steven | Director | 2012-06-21 | 2013-11-29 |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Director | 2012-06-21 | 2022-04-06 |
| GLAXO GROUP LIMITED | Corporate Director | 2012-06-21 | 2022-04-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Haleon Uk Holdings (No.3) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-09-01 | Active |
| Gsk Consumer Healthcare Holdings (No.5) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-06-28 | Ceased 2021-09-01 |
| Prism Pch Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-12-13 | Ceased 2021-06-28 |
| Consumer Healthcare Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-07-02 | Ceased 2019-12-13 |
| Glaxosmithkline Consumer Healthcare Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2019-07-02 |
Filing timeline
Last 20 of 99 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-02-07 RESOLUTIONS Resolution
- 2025-02-07 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-09-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-21 | AA | accounts | Accounts with accounts type full | |
| 2025-06-20 | CH01 | officers | Change person director company with change date | |
| 2025-04-25 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-07 | RESOLUTIONS | resolution | Resolution | |
| 2025-02-07 | MA | incorporation | Memorandum articles | |
| 2024-09-12 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-09-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-22 | AA | accounts | Accounts with accounts type full | |
| 2023-10-06 | PSC05 | persons-with-significant-control | Change to a person with significant control without name date | |
| 2023-10-05 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-09-19 | AA | accounts | Accounts with accounts type full | |
| 2023-09-14 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date | |
| 2023-06-05 | CH04 | officers | Change corporate secretary company with change date | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date | |
| 2023-06-05 | CH04 | officers | Change corporate secretary company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31